🕵️ Neuropace Inc ($NPCE)
SEC insider & ownership activity, last 12 months · CIK 1528287 · every row links its SEC filing
Over the last 12 months insiders sold $399K with no open-market buying against it. Morrell Martha sold $399K in discretionary trades (Dec). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $399K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Morrell Martha | 0 | – | 1 | $399K | Dec 15, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Polar Capital Holdings PLC | 9.1% | 13G | May 15, 2025 | filing ↗ | |
| Polar Capital LLP | 9.1% | 13G | May 15, 2025 | filing ↗ | |
| Soleus Capital Management, L.P. | 8.9% | 13G | Nov 7, 2025 | filing ↗ | |
| Soleus GP, LLC | 8.9% | 13G | Nov 7, 2025 | filing ↗ | |
| Guy Levy | 8.9% | 13G | Nov 7, 2025 | filing ↗ | |
| Mathew P. Arens | 8.7% | 13G | May 15, 2026 | filing ↗ | |
| First Light Asset Management, LLC | 8.4% | 13G | May 15, 2026 | filing ↗ | |
| Morgan Stanley | 8.3% | 13G | Feb 4, 2025 | filing ↗ | |
| Morgan Stanley Capital Services LLC | 8.2% | 13G | Feb 4, 2025 | filing ↗ | |
| Soleus Capital Master Fund, L.P. | 7.9% | 13G | Nov 7, 2025 | filing ↗ | |
| Soleus Capital, LLC | 7.9% | 13G | Nov 7, 2025 | filing ↗ | |
| Soleus Capital Group, LLC | 7.9% | 13G | Nov 7, 2025 | filing ↗ | |
| Orbimed Advisors LLC | 6.2% | 13G | May 15, 2026 | filing ↗ | |
| Orbimed Capital GP VI LLC | 6.2% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Martha J Morrell | $405K | Dec 15, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 28, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 5, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Earnings (2.02) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Earnings (2.02) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |